Fatma Ece COPUROGLU, Fatma Zehra HAPİL, Şükran Burçak YOLDAŞ, Osman Nidai ÖZEŞ

Positive regulation of TNFR1 signaling via SH3 recognition motif

TNF is a pleiotropic cytokine and shows its biological function by binding to its receptors called TNFR1 and TNFR2. While TNFR1 induces apoptosis by activation of caspase-8 via the "death domain", it also activates IKK alpha/ss, MKK3/6, MKK4/7 by activation of TAK1. Although the TNFR1 signaling pathway is known by in large, it is not known how AKT and MAPKs p38, ERK1/2, and JNK1/2 are activated. The presence of a proline-rich PPAP region, (P(448)PAP(451), a binding site for the SH3 domain-containing proteins) very close to the C-terminus promoted us to determine whether this region has any role in the TNFR1 signal transduction. To test this, the codons of P 448 and P 451 were changed to that of Alanin, GCG, via site-directed mutagenesis, and this plasmid was named as TNFR1-SH3-P/A. Subsequently, ectopically expressed the wild type TNFR1 and TNFR1-SH3-P/A in 293T cells and determined the levels of TNF-alpha-mediated phosphorylations of ERK, p38, JNK and AKT, NF-kB, and caspase-8 activation. While ectopic expression of our mutant diminished TNF alpha-mediated phosphorylations of p38, JNK, ERK and AKT, it increased NF-kB, and caspase-8 activations. In conclusion, TNF alpha-mediated ERK, AKT, JNK, p38 activations are affected by TNFR1 SH3 domain modifications.

Keywords:

TNF-α TNFR1, Grb2, ERK, AKT,

PDF

___

Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014
Boone E, 1998, FEBS LETT, V441, P275, DOI 10.1016/S0014-5793(98)01567-1
Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026
Fan YH, 2010, J BIOL CHEM, V285, P5347, DOI 10.1074/jbc.M109.076976
Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816
GRELL M, 1994, J IMMUNOL, V153, P1963 .
Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013
Hapil FZ, 2020, J INTERF CYTOK RES, V40, P225, DOI 10.1089/jir.2019.0128
He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021
Hildt E, 1999, J EXP MED, V189, P1707, DOI 10.1084/jem.189.11.1707
HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5
Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6
Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8
Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945
Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169
Legarda D, 2016, CELL REP, V15, P2449, DOI 10.1016/j.celrep.2016.05.032
Malynn BA, 2009, J EXP MED, V206, P977, DOI 10.1084/jem.20090765
Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X
OPIPARI AW, 1990, J BIOL CHEM, V265, P14705
Ozes ON, 1999, NATURE, V401, P82 .
Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298
Park SM, 2004, FEBS LETT, V566, P151, DOI 10.1016/j.feblset.2004.04.021
Patel P, 2019, BIOCHEM J, V476, P2835, DOI 10.1042/BCJ20190410
Pincheira R, 2008, J IMMUNOL, V181, P1288, DOI 10.4049/jimmunol.181.2.1288
RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0
Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3
Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009
Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016
Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973
Steelman LS, 2011, AGING-US, V3, P192, DOI 10.18632/aging.100296
TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2
Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821
Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803
Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200
Verhelst K, 2014, EMBO REP, V15, P734, DOI 10.15252/embr.201439014
Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597
Won M, 2010, CELL DEATH DIFFER, V17, P1830, DOI 10.1038/cdd.2010.47
Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006
Zou JR, 2019, MOL MED REP, V19, P759, DOI 10.3892/mmr.2018.9712